Titan Pharmaceuticals
TTNP
#11031
Rank
NZ$11.05 M
Marketcap
NZ$8.31
Share price
-3.76%
Change (1 day)
17.81%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): NZ-$7.22

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$7.91. In 2023 the company made an earnings per share (EPS) of NZ-$13.36 an increase over its 2022 EPS that were of NZ-$27.38.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.22
2023NZ-$13.36-51.22%
2022NZ-$27.38-15.61%
2021NZ-$32.45-81.37%
2020NZ-$174.13-77.52%
2019NZ-$774.76-56.32%
2018NZ-$1,774-59.51%
2017NZ-$4,381-371.81%
2016NZ$1,612-144.35%
2015NZ-$3,634300%
2014NZ-$908.52-121.54%
2013NZ$4,218-151.38%
2012NZ-$8,209-11.54%
2011NZ-$9,280188.89%
2010NZ-$3,212-10%
2009NZ-$3,569
2007NZ-$14,634-2.38%
2006NZ-$14,991-39.13%
2005NZ-$24,627-16.87%
2004NZ-$29,624-22.43%
2003NZ-$38,1904.9%
2002NZ-$36,40661.9%
2001NZ-$22,486-13.7%
2000NZ-$26,05565.01%
1999NZ-$15,790-35.87%
1998NZ-$24,623-1824.71%
1997NZ$1,428-102.4%
1996NZ-$59,605

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.05-252.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.46-219.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ-$8.35 5.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ-$0.36-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ-$0.41-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.84-0.91%๐Ÿ‡บ๐Ÿ‡ธ USA